Fiera Capital (Canada)
GHDX

Fiera Capital (Canada)’s Genomic Health, Inc. GHDX Stock Holding History

Fiera Capital (Canada)’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-262,459
Closed -$17.8M – 694
2019
Q3 		$17.8M Sell
262,459
-7,293
-3% -$501K 0.07% 174
2019
Q2 		$15.7M Sell
269,752
-17,679
-6% -$1.05M 0.06% 184
2019
Q1 		$20.1M Buy
+287,431
New +$21.3M 0.08% 173

Fiera Capital (Canada)'s GHDX Position: Q4 2019 in Review

Fiera Capital (Canada) sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 262,459 shares — an estimated $17.8M sold.

Fiera Capital (Canada) first reported a position in GHDX in Q1 2019 and held it in 3 quarters. The position peaked at $20.1M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Fiera Capital (Canada) reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Fiera Capital (Canada) sold 262,459 Genomic Health, Inc. shares in Q4 2019, an estimated $17.8M.
  • Fiera Capital (Canada) first reported a position in Genomic Health, Inc. in Q1 2019 and held it in 3 quarters.
  • Fiera Capital (Canada)'s Genomic Health, Inc. position peaked at $20.1M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Fiera Capital (Canada)'s 13F filing for Q4 2019, filed 6 Feb 2020.